RadNet partners with Desert Oasis Healthcare to provide AI-enhanced breast cancer detection at no extra cost.
Key Details
- 1RadNet partners with Desert Oasis Healthcare to deploy Enhanced Breast Cancer Detection (EBCD) program.
- 2EBCD utilizes AI to identify suspicious breast areas possibly missed by radiologists.
- 3The program is now offered to Desert Oasis patients without extra fees; previously, there was up to a $60 out-of-pocket charge since its 2022 launch.
- 4AI-based EBCD users are 21% more likely to have breast cancer detected, per recent research.
Why It Matters
This partnership increases access to advanced AI-powered breast imaging for early cancer detection, eliminating cost barriers and potentially improving patient outcomes. Increased adoption and integration of imaging AI can accelerate early diagnosis and demonstrate real-world value in clinical practice.
Source
Radiology Business
Related News
•Radiology Business
RadNet's DeepHealth Receives FDA Clearance for Chest X-ray AI Tool
RadNet's DeepHealth receives FDA 510(k) clearance for AI-powered chest X-ray abnormality detection.
•Radiology Business
Real-World Study: Radiology AI Best in Emergency and Inpatient Settings
A commercial AI tool for intracranial aneurysm detection outperformed in inpatient and emergency settings but yielded limited benefits for outpatients in a major health system study.
•Radiology Business
UCLA Review Evaluates Breast AI for Early Cancer Detection
A UCLA-led review analyzes current evidence for AI tools in screening mammography, focusing on their capability to detect interval cancers.